Benchmark Reiterates Buy on Quanex Building Prods, Maintains $31 Price Target
Benchmark analyst Reuben Garner reiterates Quanex Building Prods (NYSE:NX) with a Buy and maintains $31 price target.
RBC Capital Reiterates Sector Perform on MFA Finl, Maintains $11 Price Target
RBC Capital analyst Kenneth Lee reiterates MFA Finl (NYSE:MFA) with a Sector Perform and maintains $11 price target.
RBC Capital Reiterates Outperform on Chimera Investment, Maintains $7 Price Target
RBC Capital analyst Kenneth Lee reiterates Chimera Investment (NYSE:CIM) with a Outperform and maintains $7 price target.
RBC Capital Reiterates Outperform on American Water Works, Maintains $180 Price Target
RBC Capital analyst Shelby Tucker reiterates American Water Works (NYSE:AWK) with a Outperform and maintains $180 price target.
Credit Suisse Reiterates Outperform on Inhibrx, Maintains $46 Price Target
Credit Suisse analyst Judah Frommer reiterates Inhibrx (NASDAQ:INBX) with a Outperform and maintains $46 price target.
JMP Securities Reiterates Market Outperform on Guidewire Software, Maintains $95 Price Target
JMP Securities analyst Joe Goodwin reiterates Guidewire Software (NYSE:GWRE) with a Market Outperform and maintains $95 price target.
JMP Securities Reiterates Market Outperform on Cytokinetics, Maintains $71 Price Target
JMP Securities analyst Jason Butler reiterates Cytokinetics (NASDAQ:CYTK) with a Market Outperform and maintains $71 price target.
HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $45 Price Target
HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $45 price target.
HC Wainwright & Co. Reiterates Buy on Stoke Therapeutics, Maintains $35 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $35 price target.
EF Hutton Reiterates Buy on Amprius Technologies, Maintains $14 Price Target
EF Hutton analyst Chip Moore reiterates Amprius Technologies (NYSE:AMPX) with a Buy and maintains $14 price target.